Do you need a doctor consultation for peptide therapy?

Yes, if the therapy involves a prescription, medical screening, pharmacy dispensing, or meaningful safety questions. A licensed clinician should review history, medications, risks, product fit, and state-specific availability before any prescription decision. Approval is not guaranteed.

Sometimes. Telehealth can be appropriate when the clinician can safely evaluate the patient online and the requested care is legally and clinically appropriate. Some patients need labs, records, primary care, specialist input, urgent care, or in-person evaluation first.

Before paying, confirm whether clinician review occurs before approval, what services are included, whether treatment can be declined, what product and pharmacy pathway may be used, what costs are separate, and how cancellation or non-approval is handled.

No. A consultation is a medical evaluation and prescription decision process when treatment is appropriate. Buying peptides from no-prescription marketplaces, research-chemical sellers, or sites that provide generic dose charts for human use is a red flag.

Yes. Patients should know whether a medication is an FDA-approved branded product, an individualized compounded prescription, off-label for a goal, topical/cosmetic, or evidence-limited. Compounded finished drug products are not FDA-approved in the same way as approved brand-name drugs.

That can be appropriate. A responsible clinician may decline treatment, request labs or records, adjust the goal, recommend non-medication steps, or refer to primary care, urgent care, dermatology, cardiology, endocrinology, psychiatry, or another specialist when safer.